Jesse Leissa

Jesse Leissa is an Associate Principal Scientist in the Early Stage Formulation Sciences group at AstraZeneca, specializing in the formulation development of biologic modalities, including antibodies and antibody-drug conjugates. Previously, Jesse held various roles at AstraZeneca, contributing to early-stage formulation efforts. Jesse earned a Master’s degree in Chemical Engineering from the University of Maryland and a Bachelor’s degree from The Ohio State University. Additionally, Jesse gained research experience as a Graduate Student Researcher and as a Summer Intern at the FDA.